AGAP2 and central nervous system cancer: According to Yu et al., exosomes derived from miR-199a-overexpressing MSCs inhibit glioma progression through down-regulating AGAP2 [31], and Lou et al. state that exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of liver cancer [32].